05-Feb-2020 - Carl Zeiss AG

ZEISS and RIKEN Innovation establish partnership in bioengineering and data management

Synergizing RIKEN's excellence in basic research in bioengineering with ZEISS's expertise in imaging and sensing

ZEISS and RIKEN Innovation Co., Ltd. entered into a strategic collaboration agreement to jointly explore opportunities in aiming to identify projects where the combination of RIKEN’s expertise in bioengineering and image data manipulation and ZEISS’ leadership in optical solutions can accelerate bioengineering innovations and bring about a paradigm change in health care.

“We are proud to complement RIKEN’s broad-spectrum and extensive basic research through our expertise in biomedical imaging, which we see as a fundamental ingredient for turning bioengineering into viable healthcare solutions. The success of leading-edge research requires not only groundbreaking ideas but also access and management of advanced scientific equipment. Highest level of instrument availability and advanced image data management are key to efficient R&D”, said Dr. Stefan Sacré, Head of ZEISS in Japan.

RIKEN’s extensive R&D infrastructure and imaging resources provide an excellent base for collaboration between RIKEN and ZEISS. Hiroshi Matsumoto, President of RIKEN, commented, “Today’s Agreement with ZEISS, a corporation which has earned a high level of trust world-wide as a manufacturer of high-precision microscopes and optical instruments, represents a new kind of partnership that does not merely focus on separate research topics. I look forward to an environment in which our partners at ZEISS and researchers at RIKEN engage in free and open discussions, and for RIKEN Innovation to support both organizations in their strategic planning. I expect that this will lead to collaborative research activity of the highest level and the pioneering of new fields.”

Facts, background information, dossiers
  • image data manipulation
More about Carl Zeiss
  • News

    Tenth Record-Breaking Year in a Row for ZEISS

    The ZEISS Group continued its growth trajectory, with revenue and earnings reaching new heights in fiscal year 2018/19, which ended 30 September 2019. Revenue grew by 11 percent, reaching 6.428 billion euros (previous year: 5.817 billion euros). Adjusted for currency and acquisition effects ... more

    ZEISS and Senorics Establish Partnership

    ZEISS’ investment in Senorics marks the start of a technology collaboration with the sensorics startup based in Dresden, Germany. The partnership aims to further the joint development of small and cost-effective sensors for industrial use in quality assurance and in process monitoring, e.g. ... more

    ZEISS Opts for Continuity with New CEO

    At its meeting on 24 September 2019, the Supervisory Board of Carl Zeiss AG unanimously voted in favor of the following changes to the Executive Board: Dr. Karl Lamprecht, currently a Member of the Executive Board, will become the new President & CEO effective 1 April 2020. With this appoin ... more

  • Companies

    Carl Zeiss Vision GmbH

    Having been founded in 2005, Carl Zeiss Vision is the new leader in ophthalmic products. We provide the consumer and the eyecare professional with quality spectacle lenses, diagnostic tools, services and support in business and marketing. more

    Carl Zeiss AG

    Carl Zeiss AG is a leading group of companies operating worldwide in the optical and opto-electronic industry. The five independently operating business groups are active in the future-oriented markets of Medical and Research Solutions, Industrial Solutions and Lifestyle Products. Founded i ... more

    Carl Zeiss Jena GmbH

    Carl Zeiss designs and manufactures spectral sensors from 0.9-2.2 µm. We also deliver On-line, At-line and In-Line spectrometer systems for concentration, layer thickness and colour measurement. Specially configurations for pharma and food industry. more

More about RIKEN